Needham & Company LLC Cuts Clearside Biomedical (NASDAQ:CLSD) Price Target to $3.00
Clearside Biomedical (NASDAQ:CLSD – Free Report) had its price objective reduced by Needham & Company LLC from $4.00 to $3.00 in a research note published on Thursday morning,Benzinga reports. They currently have a buy rating on the stock. CLSD has been the topic of several other research reports. Chardan Capital reissued a “buy” rating and […]
Clearside Biomedical (NASDAQ:CLSD – Free Report) had its price objective reduced by Needham & Company LLC from $4.00 to $3.00 in a research note published on Thursday morning,Benzinga reports. They currently have a buy rating on the stock. CLSD has been the topic of several other research reports. Chardan Capital reissued a “buy” rating and […]
